August 17, 2021
1 min watch
Gandara reports receiving institutional research grants from Amgen, AstraZeneca, Genentech and Merck; and serving as a consultant or on advisory boards for AstraZeneca (institutional), Roche-Genentech (institutional), Guardant Health (institutional), Inivata, IO Biotech (institutional), Lilly, Merck, Novartis and Oncocyte (institutional)
In this video, David R. Gandara, MD, spoke with Healio about discussions surrounding the ADAURA trial held at the 22nd annual International Lung Cancer Congress.
“We use this opportunity at ILCC to both update the data and to have a panel discussion regarding how we’re using this information in practice,” Gandara, director of the thoracic oncology program at UC Davis Comprehensive Cancer Center and chief medical officer for the International Society of Liquid Biopsy, said.